MediJane Holdings Inc. Retains Investment Banking Firm Moody Capital Solutions, Inc. for Corporate Growth and Expansion
LONGMONT, CO--(Marketwired - Aug 12, 2014) - MediJane Holdings Inc. (OTCQB: MJMD) ("MediJane" or the "Company") a medical cannabis company focused on the wholesale sales and distribution of smokeless medical cannabis products, is pleased to announce that it has retained the services of Moody Capital Solutions, Inc. (FINRA/SIPC member) to assist with its rapid expansion strategy.
Moody Capital provides capital raising, merger and acquisition services, and other investment banking services to both publicly listed and privately held small/micro-cap companies. Moody Capital's senior bankers have extensive experience in community banking, healthcare, life sciences, alternative energy, electronics manufacturing, and technology. Moody's experience includes capital raises directly with the public and utilizing extensive relationships with leading institutional investors, including private equity firms, venture capital firms, hedge funds and other alternative funding sources.
For more information visit Moody Capital Solutions, Inc. on the Internet at www.MoodyCapital.com.
"We are delighted to assist management of MediJane as they bring these revolutionary cannabis delivery methods to market that could prove to be a viable alternative to retail pharmaceuticals that currently dominate the industry," stated David Pitt, Managing Director of Moody Capital.
Moody Capital has been engaged by the Company to provide a conduit of equity investment capital to allow MediJane to execute on its national rollout strategy, including new states, additional products, and an aggressive acquisition strategy. Moody's experience in financing the medical marijuana industry includes acting as the lead broker on funding Medbox, Inc. (MDBX).
"This engagement is extremely important for MediJane Holdings Inc. on two fronts; it provides the Company with strong banking relationships and ensures effective access to long term capital. Our relationship with Moody Capital also advances and enhances our key focus on corporate compliance to ensure transparency for our shareholders. Bringing David and his team on board represents the start of the next phase of growth and development of MediJane," stated Lewis "Spike" Humer, Chairman.
About MediJane Holdings Inc. (MJMD)
MediJane Holdings Inc. (MJMD) is in the business of marketing and distributing products within the medical marijuana industry, including transdermal patches, capsules, sublingual sprays, oral strips, and other medical delivery systems as part of its strategic alliances with Phoenix Bio Pharmaceuticals (www.phoenixbiopharmaceuticals.com). With sales offices opening in California and Colorado, and a planned expansion into a national footprint, MediJane products are designed to give doctors the ability to provide patients accurate and effective doses of cannabinoids to manage and treat pain and other specific illnesses. MediJane's products, including the innovative non-drowsy "Daytime Pain plus CBD" oral capsule, the CannaMist cannabinoid spray, and MediStrip Relaxation oral strips, have been formulated for the treatment of inflammation and chronic, neuropathic, arthritic, and back pain. These smokeless alternatives provide accurate dosages and are part of MediJane's launch into the chronic pain management market. Any and all medically oriented statements have not been evaluated by the Food and Drug Administration.
For more information, visit www.medijane.co
Disclaimer/Safe Harbor: Some information in this MediJane press release constitutes forward-looking statements or statements which may be deemed or construed to be forward-looking statements. The words "plan", "forecast", "anticipates", "estimate", "project", "intend", "expect", "should", "believe," and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to, known and unknown risks, uncertainties and other factors which could cause MediJane's actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in MediJane's filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to MediJane herein are expressly qualified in their entirety by the above-mentioned cautionary statement. MediJane disclaims any obligation to update forward-looking statements contained in this press release, except as may be required by law.
